Simultaneous increases in respiration and sympathetic function during opiate detoxification

Journal of Neurosurgical Anesthesiology

Volumn 10, Issue 4, 1998, Pages 205-210

  Hoffman, William E ^a   McDonald, Timothy ^a   Berkowitz, Richard ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Addiction; Anesthesia; Brain; Naltrexone; Opioids; Propofol; Sympathetic Ventilation

Indexed keywords

CLONIDINE; DIAMORPHINE; HYDROCODONE; METHADONE; MIDAZOLAM; NALTREXONE; OPIATE; OPIATE RECEPTOR; PROPOFOL; ROCURONIUM;

ADULT; ARTICLE; BLOOD PRESSURE; BREATHING; CLINICAL ARTICLE; DETOXIFICATION; DRUG DEPENDENCE; DRUG EFFECT; DRUG WITHDRAWAL; FEMALE; HEART RATE VARIABILITY; HUMAN; LUNG MINUTE VOLUME; MALE; PRIORITY JOURNAL; SYMPATHETIC TONE;

EID: 0031680547     PISSN: 08984921     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008506-199810000-00001     Document Type: Article

References (28)

1. Rabinowitz J, Cohen H, Tarrasch R, and Kotler M. (1997). Compliance to Naltrexone Treatment after Ultra Rapid Opioid Detoxification: An Open Label Naturalistic Study. Drug & Alcohol Depend 1997;47:77-86
2. Legarda JJ, and Gossop M. 24-Hour Inpatient Detoxification Treatment for Heroin Addicts: A Preliminary Investigation. Drug & Alcohol Depend 1994;35:91-93
3. Sebel PS, Lang E, Rampil IJ, White PF, Fanzca, Cork R, Jopling M, Smith NT, Glass PSA, Manberg P. A multicenter study of bispectral electroencephalogram analysis for monitoring anesthetic effect. Anesth Analg 1997;84:891-9
4. Tetzlaff JE, O'Hara J Jr, Yoon HJ, Schubert A. Tourniquet induced hypertension correlates with autonomic nervous system changes detected by power spectral heart rate analysis. J Clin Invest 1997;9:138-42
5. Tetzlaff JE, O'Hara J, Yoon HJ, Schubert AG. Power spectral heart rate analysis demonstrates decreased activity of the sympathetic nervous system during low bupivacaine spinal anesthesia. J Clin Anes 1998;10:133-6
6. Hopf HB, Skychally A, Heusch G, Peters J. Low frequency spectral power of heart rate variability is not a specific marker of cardiac sympathetic modulation. Anesthesiology 1995;82:609-19
7. Sebel PS, Lang E, Rampil IJ, White PF, Fanzca, Cork R, Jopling M, Smith NT, Glass PSA, Manberg P. A multicenter study of bispectral electroencephalogram analysis for monitoring anesthetic effect. Anesth Analg 1997;84:891-9
8. Rasmussen K, Beitner-Johnson D, Aghajanian GK, Nestler EJ. Opiate withdrawal and the rat locus coeruleus: behavioral, electrophysiological, and biochemical correlates. J Neurosci 1990;10:2308-17
9. Baraban SC, Stornetta RL, Guyenet PG. Effects of morphine and morphine withdrawal on adrenergic neurons of the rat rostral ventrolateral medulla. Brain Res 1995;676:345-57
10. Trouth CO, Bada FJ, Pan Y, Holloway JA, Millis RM, Bernard DG. Naloxone application to the ventrolateral medulla enhances the respiratory response to inspired carbon dioxide. Life Sci 1991;49: 193-200
11. Gerra G, Marcato A, Caccavari R, Fontanesi B, Delisignore R, Fertonani G, Avanzini P, Rustichelli P, Passeri M. Clonidine and opiate receptor antagonists in the treatment of heroin addiction. J Subst Abuse Treat 1995;12:35-41
12. Charney DS, Henniger GR, Kleber HD. The combined use of clonidine and naltrexone as a rapid, safe, and effective treatment of abrupt withdrawal from methadone. Am J Psychiatry 1986;143:831-7
13. Sun MK. Central neural organization and control of sympathetic nervous system in mammals. Prog Neurobiol 1995;47:157-233
14. Brown DL, Guyenet PG. Cardiovascular neurons of brain stem with projections to spinal cord. Am J Physiol 1984;247:R1009-16
15. Milner Ta, Pickel VM, Reis DJ. Tyrosine hydroxylase and enkephalin in the rostral ventrolateral medulla: major synaptic contacts from opioid terminals on catecholaminergic synaptic contacts from opioid terminals on catecholaminergic neurons. Prog Clin Biol Res 1990;328:195-8
16. Cerutti C, Gustin MP, Paultre CZ, Lo M, Julien C, Vincent M, Sassard J. Autonomic nervous system and cardiovascular variability in rats: a spectral analysis approach. Am J Physiol 1991;261:H1292-9
17. Deutschman CS, Harris AP, Fleisher LA. Changes in heart rate variability under propofol anesthesia: a possible explanation for propofol induced bradycardia. Anesth Analg 1994;79:373-7
18. Lawson EE, Waldrop TG, Eldrige FL. Naloxone enhances respiratory output in cats. J Appl Physiol 1979;47:1105-11
19. Olson BE Jr. Naloxone accelerates the rate of ventilatory acclimatization to hypoxia in awake rats. Life Sci 1987;41:161-7
20. Pokorski M, Lahiri S. Effects of naloxone on carotid body chemoreception and ventilation in the cat. J Appl Physiol 1981;51:1533-8
21. Schlenker EH, Inamdar SR. Effects of naloxone on oxygen consumption and ventilation in awake golden Syrian hamsters. Physiol Behav 1995;57:655-8
22. Van Loon GR. Opioid peptide regulation of catecholamine secretion. In: Fraioli F, Isodor A, Massetti M eds. Opioid peptides in the periphery. Amsterdam: Elesevier Science Publishers; 1984:48-53
23. Moller N, Nyholm B, Prksen N, Alberti GMM, Weeke J. Glucose turnover, fuel oxidation and forearm substrate exchange in patients with thyrotoxicosis before and after medical treatment. Clin Endocrinol 1996;44:453-9
24. Gronert GA, Theye RA. Halothane-induced porcine malignant hyperthermia: metabolic and hemodynamic changes. Anesthesiology 1976;44:36-43
25. Wanke-Jellinek C, Missaghi SM, Czech K. Hypercapnia and mixed acidosis as the only sign of malignant hyperthermia (MH)? Anaesthesist 1994;43:553-6
26. Tan WC, Cheah JS. The role of sympathomimetic amines in the dyspnea of thyrotoxicosis. Ann Acad Med Singapore 1983;12:462-5
27. Gonzalez JP, Brogden RN. Naltrexone, a review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the management of opioid dependence. Drugs 1988;35:192-213
28. Roizen MF, Horrigan RW, Frazer BM. Anesthetic doses blocking adrenergic (stress) and cardiovascular responses to incision-MAC BAR. Anesthesiology 1981;54:390-6